{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T16:20:02Z","timestamp":1777738802199,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M741378"],"award-info":[{"award-number":["2023M741378"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009102","name":"Jiangxi Provincial Department of Education","doi-asserted-by":"publisher","award":["GJJ2401308"],"award-info":[{"award-number":["GJJ2401308"]}],"id":[{"id":"10.13039\/501100009102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103542"],"award-info":[{"award-number":["82103542"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.molimm.2025.11.006","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T11:41:10Z","timestamp":1764157270000},"page":"192-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Complement factor D is a drug target for metabolic-associated fatty liver disease"],"prefix":"10.1016","volume":"188","author":[{"given":"Rong","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zilin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junxiang","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenfang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongxia","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2025.11.006_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.712572","article-title":"Complement Factor D as a strategic target for regulating the alternative complement pathway","volume":"12","author":"Barratt","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2025.11.006_bib2","article-title":"Oral administration of the Complement Factor D inhibitor danicopan (ALXN2040) in preclinical studies demonstrates high and sustained drug concentrations in posterior ocular tissues for the potential treatment of geographic atrophy","volume":"62","author":"Boyer","year":"2021","journal-title":"Invest Ophth Vis. Sci."},{"key":"10.1016\/j.molimm.2025.11.006_bib3","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.11.10.37","article-title":"Danicopan, an oral complement factor d inhibitor, exhibits high and sustained exposure in ocular tissues in preclinical studies","volume":"11","author":"Boyer","year":"2022","journal-title":"Transl. Vis. Sci. Techn"},{"key":"10.1016\/j.molimm.2025.11.006_bib4","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molimm.2025.11.006_bib5","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.numecd.2022.11.007","article-title":"MAFLD is associated with increased all-cause mortality in low cardiovascular-risk individuals but not in intermediate to high-risk individuals","volume":"33","author":"Chen","year":"2023","journal-title":"Nutr. Metab. Cardiovas."},{"key":"10.1016\/j.molimm.2025.11.006_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12944-025-02483-z","article-title":"Fucoidan ameliorates lipid accumulation, oxidative stress, and NF-kappaB-mediated inflammation by regulating the PI3K\/AKT\/Nrf2 signaling pathway in a free fatty acid-induced NAFLD spheroid model","volume":"24","author":"Chu","year":"2025","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.molimm.2025.11.006_bib7","first-page":"618","article-title":"Iptacopan and danicopan for paroxysmal nocturnal hemoglobinuria","volume":"30","author":"Fahim","year":"2024","journal-title":"J. Manag Care Spec. Pharm."},{"key":"10.1016\/j.molimm.2025.11.006_bib8","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.stem.2023.09.001","article-title":"Complement factor D targeting protects endotheliopathy in organoid and monkey models of COVID-19","volume":"30","author":"Kawakami","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molimm.2025.11.006_bib9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000024413","article-title":"Synthesis of factor D by normal human hepatocytes","volume":"122","author":"Kitano","year":"2000","journal-title":"Int. Arch. Allergy Imm"},{"key":"10.1016\/j.molimm.2025.11.006_bib10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1182\/blood.2024026299","article-title":"Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVH","volume":"145","author":"Kulasekararaj","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2025.11.006_bib11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.preteyeres.2016.04.003","article-title":"Risk factors and biomarkers of age-related macular degeneration","volume":"54","author":"Lambert","year":"2016","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.molimm.2025.11.006_bib12","article-title":"Dominant-negative HNF1\u03b1 mutant promotes liver steatosis and inflammation by regulating hepatic complement factor D","volume":"26","author":"Liu","year":"2023","journal-title":"Iscience"},{"key":"10.1016\/j.molimm.2025.11.006_bib13","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrin Met"},{"key":"10.1016\/j.molimm.2025.11.006_bib14","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1053\/j.gastro.2020.01.051","article-title":"Therapeutic landscape for NAFLD in 2020","volume":"158","author":"Neuschwander-Tetri","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molimm.2025.11.006_bib15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/joim.13531","article-title":"Current treatment of non-alcoholic fatty liver disease","volume":"292","author":"Paternostro","year":"2022","journal-title":"J. Intern Med."},{"key":"10.1016\/j.molimm.2025.11.006_bib16","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.3390\/ijms15058591","article-title":"Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation","volume":"15","author":"Peverill","year":"2014","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.molimm.2025.11.006_bib17","article-title":"MAFLD: a multisystem disease","volume":"14","author":"Pipitone","year":"2023","journal-title":"Ther. Adv. Endocrinol."},{"key":"10.1016\/j.molimm.2025.11.006_bib18","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.3324\/haematol.2020.261826","article-title":"Danicopan: an oral complement factor D inhibitor for paroxysmal nocturnal hemoglobinuria","volume":"106","author":"Risitano","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.molimm.2025.11.006_bib19","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1126\/science.2734615","article-title":"Adipsin and complement factor D activity: an immune-related defect in obesity","volume":"244","author":"Rosen","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.molimm.2025.11.006_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41581-018-0107-2","article-title":"C3 glomerulopathy - understanding a rare complement-driven renal disease","volume":"15","author":"Smith","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.molimm.2025.11.006_bib21","article-title":"Small Molecule-Induced Complement Factor D (Adipsin) promotes lipid accumulation and adipocyte differentiation","volume":"11","author":"Song","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2025.11.006_bib22","doi-asserted-by":"crossref","first-page":"8828","DOI":"10.1167\/iovs.11-7933","article-title":"Complement Factor D in age-related macular degeneration","volume":"52","author":"Stanton","year":"2011","journal-title":"Invest Ophth Vis. Sci."},{"key":"10.1016\/j.molimm.2025.11.006_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74617-5","article-title":"HFD-induced hepatic lipid accumulation and inflammation are decreased in Factor D deficient mouse","volume":"10","author":"Tsuru","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molimm.2025.11.006_bib24","doi-asserted-by":"crossref","DOI":"10.1186\/s10020-025-01237-y","article-title":"Transcriptome-wide analysis reveals potential roles of CFD and ANGPTL4 in fibroblasts regulating B cell lineage for extracellular matrix-driven clustering and novel avenues for immunotherapy in breast cancer","volume":"31","author":"Wang","year":"2025","journal-title":"Mol. Med"},{"key":"10.1016\/j.molimm.2025.11.006_bib25","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2012.10.001","article-title":"Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review","volume":"10","author":"White","year":"2012","journal-title":"Clin. Gastroenterol. H."},{"key":"10.1016\/j.molimm.2025.11.006_bib26","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.2174\/0929867326666191001130342","article-title":"Discovery and development of the oral complement Factor D inhibitor danicopan (ACH-4471)","volume":"27","author":"Wiles","year":"2020","journal-title":"Curr. Med Chem."},{"key":"10.1016\/j.molimm.2025.11.006_bib27","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1111\/bph.12681","article-title":"Reactive oxygen species induce MMP12-dependent degradation of collagen 5 and fibronectin to promote the motility of human umbilical cord-derived mesenchymal stem cells","volume":"171","author":"Yun","year":"2014","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.molimm.2025.11.006_bib28","article-title":"CD9 counteracts liver steatosis and mediates GCGR agonist hepatic effects","volume":"11","author":"Zheng","year":"2024","journal-title":"Adv. Sci. (Weinh. )"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589025002615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589025002615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:44:48Z","timestamp":1773924288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589025002615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":28,"alternative-id":["S0161589025002615"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2025.11.006","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement factor D is a drug target for metabolic-associated fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2025.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}